TABLE 1.

Patient characteristics by VT recurrence and mortality

	VT Recurrence within 12 Months			Transplant/Death within 12 Months
N (%) or median (Q1-Q3)	Yes (N=536)	No (N=1525)	p value	Yes (N=273)	No (N=1788)	p value
Age (y)	65.0 (55.0-72.0)	64.0 (54.0-72.0)	0.341	66.0 (59.0-74.0)	64.0 (54.0-72.0)	<0.001
Female	81 (15.1)	185 (12.1)	0.083	35 (12.8)	230 (12.9)	1
ICM	257 (47.9)	838 (55.0)	0.006	147 (53.8)	948 (53.0)	0.850
EF Pre-Ablation	28.0 (20.0-40.0)	35.0 (25.0-45.0)	<0.001	24.0 (20.0-30.0)	35.0 (25.0-45.0)	<0.001
NYHA			<0.001			<0.001
I	92 (18.8)	466 (32.5)		23 (8.9)	535 (32.1)
II	193 (39.5)	525 (36.6)		71 (27.6)	647 (38.8)
III	164 (33.5)	372 (25.9)		113 (44.0)	423 (25.4)
IV	40 (8.2)	71 (5.0)		50 (19.5)	61 (3.7)
ICD	487 (92.8)	1251 (84.2)	<0.001	250 (94.7)	1488 (85.2)	<0.001
CRT	165 (31.4)	348 (23.4)	<0.001	107 (40.5)	406 (23.3)	<0.001
Electrical Storm	220 (43.8)	464 (32.3)	<0.001	147 (57.4)	537 (31.9)	<0.001
ICD Shocks	344 (72.7)	869 (62.7)	<0.001	176 (76.2)	1037 (63.7)	<0.001
Hypertension	285 (58.8)	753 (56.4)	0.407	140 (58.6)	898 (56.8)	0.662
Atrial Fibrillation	163 (33.5)	394 (28.7)	0.052	97 (39.3)	460 (28.5)	0.004
Diabetes Mellitus	128 (24.4)	305 (20.6)	0.073	92 (35.4)	341 (19.5)	<0.001
Chronic Kidney Disease	169 (31.7)	436 (28.7)	0.213	126 (46.5)	479 (26.9)	<0.001
Baseline Creatinine	1.1 (0.9-1.5)	1.1 (0.9-1.4)	0.199	1.3 (1.0-1.7)	1.1 (0.9-1.3)	<0.001
Beta-Blocker	433 (81.5)	1173 (78.3)	0.123	226 (83.7)	1380 (78.4)	0.056
Amiodarone	283 (59.1)	737 (54.0)	0.061	172 (71.1)	848 (52.9)	<0.001
≥2 AAD	110 (23.0)	228 (16.7)	0.003	66 (27.3)	272 (17.0)	<0.001
Prior VT Ablations	0.0 (0.0-1.0)	0.0 (0.0-1.0)	0.019	0.0 (0.0-1.0)	0.00 (0.0-1.0)	0.001
Min-Max	0.0-7.0	0.0-10.0		0.0-6.0	0.0-10.0